@article{li_2021,
title={A Potential Effective And Innovative Therapy For The Treatment of Chronic HBV Infection And Liver Cancer},
DOI={10.5281/zenodo.4925657},
abstractNote={In a study published in Nature Communications on May 14, a research team led by scientists from University College London (UCL) found a new target for the treatment of hepatitis B. The targeted therapy of HBV can not only inhibit the replication of HBV, but also stimulate T cell activity against HBV-infected liver cells. The researchers said that this target may bring a highly effective and innovative therapy for the treatment of chronic HBV infection and liver cancer.},
publisher={Zenodo},
author={Li, Sonia},
year={2021},
month={Jun}
}